The DOI matches its Crossref record; 724 of the 724 references it cites were found in a registry or an index.
Purinergic Signalling: Therapeutic Developments
Open accessAbstract
Purinergic signalling, i.e. the role of nucleotides as extracellular signalling molecules, was proposed in 1972. However, this concept was not well accepted until the early 1990’s when receptor subtypes for purines and pyrimidines were cloned and characterised, which includes 4 subtypes of the P1 (adenosine) receptor, 7 subtypes of P2X ion channel receptors and 8 subtypes of the P2Y G protein-coupled receptor. Early studies were largely concerned with the physiology, pharmacology and biochemistry of purinergic signalling. More recently, the focus has been on the pathophysiology and therapeutic potential. There was early recognition of the use of P1 receptor agonists for the treatment of supraventicular tachycardia and A2A receptor antagonists are promising for the treatment of Parkinson’s disease. Clopidogrel, a P2Y¬12 antagonist, is widely used for the treatment of thrombosis and stroke, blocking P2Y¬12 receptor-mediated platelet aggregation. Diquafasol, a long acting P2Y¬2 receptor agonist, is being used for the treatment of dry eye. P2X3 receptor antagonists have been developed that are orally bioavailable and stable in vivo and are currently in clinical trials for the treatment of chronic cough, bladder incontinence, visceral pain and hypertension. Antagonists to P2X7 receptors are being investigated for the treatment of inflammatory disorders, including neurodegenerative diseases. Other investigations are in progress for the use of purinergic agents for the treatment of osteoporosis, myocardial infarction, irritable bowel syndrome, epilepsy, atherosclerosis, depression, autism, diabetes and cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Grenz, A., Kim, J., Bauerle, J. D., Tak, E., Eltzschig, H. K., & Clambey, E. T. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201651 · Cited by 42
RetractedReceptors for Purines and Pyrimidines
Burnstock, G., & Verkhratsky, A. (2012) · Purinergic Signalling and the Nervous System · doi:10.1007/978-3-642-28863-0_5 · Cited by 3,958
Self-citationReceptors for Purines and Pyrimidines
Ralevic, V., & Burnstock, G. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01373-5 · Cited by 2,005
Self-citationBurnstock, G. (1972) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06930-3 · Cited by 1,852
Self-citationUrinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice
Cockayne, D. A., Hamilton, S. G., Zhu, Q.-M., Dunn, P. M., Zhong, Y., Novakovic, S., Malmberg, A. B., Cain, G., Berson, A., Kassotakis, L., et al. (2000) · Nature · doi:10.1038/35039519 · Cited by 1,030
Self-citationPurine and pyrimidine receptors
Burnstock, G. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6497-0 · Cited by 929
Self-citationAdenosine receptors as drug targets — what are the challenges?
Chen, J.-F., Eltzschig, H. K., & Fredholm, B. B. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3955 · Cited by 895
Immune cell regulation by autocrine purinergic signalling
Junger, W. G. (2011) · Nature Reviews Immunology · doi:10.1038/nri2938 · Cited by 810
Cellular Distribution and Functions of P2 Receptor Subtypes in Different Systems
Burnstock, G., & Knight, G. E. (2004) · International Review of Cytology · doi:10.1016/s0074-7696(04)40002-3 · Cited by 795
Self-citationPurinergic regulation of the immune system
Cekic, C., & Linden, J. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.4 · Cited by 787
Purinergic signalling and disorders of the central nervous system
Burnstock, G. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2605 · Cited by 634
Self-citationAstrocyte-derived ATP modulates depressive-like behaviors
Cao, X., Li, L.-P., Wang, Q., Wu, Q., Hu, H.-H., Zhang, M., Fang, Y.-Y., Zhang, J., Li, S.-J., Xiong, W.-C., et al. (2013) · Nature Medicine · doi:10.1038/nm.3162 · Cited by 615
Pathophysiology and Therapeutic Potential of Purinergic Signaling
Burnstock, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.1.5 · Cited by 611
Self-citationAnti-CD73 antibody therapy inhibits breast tumor growth and metastasis
Stagg, J., Divisekera, U., McLaughlin, N., Sharkey, J., Pommey, S., Denoyer, D., Dwyer, K. M., & Smyth, M. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908801107 · Cited by 572
Extracellular purines, purinergic receptors and tumor growth
Di Virgilio, F., & Adinolfi, E. (2017) · Oncogene · doi:10.1038/onc.2016.206 · Cited by 559
Eyo, U. B., Peng, J., Swiatkowski, P., Mukherjee, A., Bispo, A., & Wu, L.-J. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0416-14.2014 · Cited by 509
P2X7 receptor inhibition improves recovery after spinal cord injury
Wang, X., Arcuino, G., Takano, T., Lin, J., Peng, W. G., Wan, P., Li, P., Xu, Q., Liu, Q. S., Goldman, S. A., et al. (2004) · Nature Medicine · doi:10.1038/nm1082 · Cited by 494
Abdulqawi, R., Dockry, R., Holt, K., Layton, G., McCarthy, B. G., Ford, A. P., & Smith, J. A. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61255-1 · Cited by 487
P2X3Knock-Out Mice Reveal a Major Sensory Role for Urothelially Released ATP
Vlaskovska, M., Kasakov, L., Rong, W., Bodin, P., Bardini, M., Cockayne, D. A., Ford, A. P. D. W., & Burnstock, G. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05670.2001 · Cited by 465
Self-citationNeutrophil P2X7 receptors mediate NLRP3 inflammasome-dependent IL-1β secretion in response to ATP
Karmakar, M., Katsnelson, M. A., Dubyak, G. R., & Pearlman, E. (2016) · Nature Communications · doi:10.1038/ncomms10555 · Cited by 450
How does adenosine control neuronal dysfunction and neurodegeneration?
Cunha, R. A. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13724 · Cited by 441
Peng, W., Cotrina, M. L., Han, X., Yu, H., Bekar, L., Blum, L., Takano, T., Tian, G.-F., Goldman, S. A., & Nedergaard, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902531106 · Cited by 424
Adiponectin Receptor as a Key Player in Healthy Longevity and Obesity-Related Diseases
Yamauchi, T., & Kadowaki, T. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.01.001 · Cited by 415
Purinergic Signaling in the Cardiovascular System
Burnstock, G. (2017) · Circulation Research · doi:10.1161/circresaha.116.309726 · Cited by 415
Self-citationPurinergic Signaling and Vascular Cell Proliferation and Death
Burnstock, G. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0302.105360 · Cited by 414
Self-citationPurinergic signalling: From normal behaviour to pathological brain function
Burnstock, G., Krügel, U., Abbracchio, M. P., & Illes, P. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.08.006 · Cited by 397
Self-citationReduced vas deferens contraction and male infertility in mice lacking P2X1 receptors
Mulryan, K., Gitterman, D. P., Lewis, C. J., Vial, C., Leckie, B. J., Cobb, A. L., Brown, J. E., Conley, E. C., Buell, G., Pritchard, C. A., et al. (2000) · Nature · doi:10.1038/47495 · Cited by 396
Adenosine activates brown adipose tissue and recruits beige adipocytes via A2A receptors
Gnad, T., Scheibler, S., von Kügelgen, I., Scheele, C., Kilić, A., Glöde, A., Hoffmann, L. S., Reverte-Salisa, L., Horn, P., Mutlu, S., et al. (2014) · Nature · doi:10.1038/nature13816 · Cited by 393
The P2X7 Receptor Channel: Recent Developments and the Use of P2X7 Antagonists in Models of Disease
Bartlett, R., Stokes, L., & Sluyter, R. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008003 · Cited by 393
P2X7 receptor: an emerging target in central nervous system diseases
Sperlágh, B., & Illes, P. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.08.002 · Cited by 390 · cited 2×
“, 2011), including the recent attention to the development of centrally penetrant P2X7R antagonists for the treatment of CNS disorders (Burnstock and Verkhratsky, 2012; Puchalowicz et al., 2014; Sperlagh and Illes, 2014; Burnstock, 2015b; Cisneros-Mejorado et al., 2015b).”
BackgroundIwata, M., Ota, K. T., Li, X.-Y., Sakaue, F., Li, N., Dutheil, S., Banasr, M., Duric, V., Yamanashi, T., Kaneko, K., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.11.026 · Cited by 387
BURNSTOCK, G. (1999) · Journal of Anatomy · doi:10.1046/j.1469-7580.1999.19430335.x · Cited by 355
Self-citationExpression of P2X7 Receptor Increases In Vivo Tumor Growth
Adinolfi, E., Raffaghello, L., Giuliani, A. L., Cavazzini, L., Capece, M., Chiozzi, P., Bianchi, G., Kroemer, G., Pistoia, V., & Di Virgilio, F. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1947 · Cited by 347
P2 receptors in cardiovascular regulation and disease
Erlinge, D., & Burnstock, G. (2008) · Purinergic Signalling · doi:10.1007/s11302-007-9078-7 · Cited by 344
Self-citationPurinergic signalling and cancer
Burnstock, G., & Di Virgilio, F. (2013) · Purinergic Signalling · doi:10.1007/s11302-013-9372-5 · Cited by 316
Self-citationKeystone, E. C., Wang, M. M., Layton, M., Hollis, S., & McInnes, I. B. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-143578 · Cited by 315
Kaster, M. P., Machado, N. J., Silva, H. B., Nunes, A., Ardais, A. P., Santana, M., Baqi, Y., Müller, C. E., Rodrigues, A. L. S., Porciúncula, L. O., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423088112 · Cited by 312
Borea, P. A., Gessi, S., Merighi, S., & Varani, K. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.02.006 · Cited by 311
Purinergic Signaling and Blood Vessels in Health and Disease
Burnstock, G., & Ralevic, V. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008029 · Cited by 303
Self-citationLayland, J., Carrick, D., Lee, M., Oldroyd, K., & Berry, C. (2014) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2014.02.009 · Cited by 297
Naviaux, J. C., Wang, L., Li, K., Bright, A., Alaynick, W. A., Williams, K. R., Powell, S. B., & Naviaux, R. K. (2015) · Molecular Autism · doi:10.1186/2040-2392-6-1 · Cited by 285
Adenosine A 2A Receptor as a Drug Discovery Target
de Lera Ruiz, M., Lim, Y.-H., & Zheng, J. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4011669 · Cited by 276
Medicinal chemistry of adenosine, P2Y and P2X receptors
Jacobson, K. A., & Müller, C. E. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.12.001 · Cited by 262
ATP as a multi-target danger signal in the brain
Rodrigues, R. J., Tomé, A. R., & Cunha, R. A. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00148 · Cited by 259
The A3 Adenosine Receptor: History and Perspectives
Borea, P. A., Varani, K., Vincenzi, F., Baraldi, P. G., Tabrizi, M. A., Merighi, S., & Gessi, S. (2015) · Pharmacological Reviews · doi:10.1124/pr.113.008540 · Cited by 244
Microglia in the spinal cord and neuropathic pain
Tsuda, M. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12379 · Cited by 240
Arulkumaran, N., Unwin, R. J., & Tam, F. W. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.578068 · Cited by 239
Common variants in P2RY11 are associated with narcolepsy
Kornum, B. R., Kawashima, M., Faraco, J., Lin, L., Rico, T. J., Hesselson, S., Axtell, R. C., Kuipers, H., Weiner, K., Hamacher, A., et al. (2011) · Nature Genetics · doi:10.1038/ng.734 · Cited by 237
Jacob, F., Novo, C. P., Bachert, C., & Van Crombruggen, K. (2013) · Purinergic Signalling · doi:10.1007/s11302-013-9357-4 · Cited by 232
Purinergic signaling in the immune system
Di Virgilio, F., & Vuerich, M. (2015) · Autonomic Neuroscience · doi:10.1016/j.autneu.2015.04.011 · Cited by 231
Adenosine A2Areceptors play a role in the pathogenesis of hepatic cirrhosis
Chan, E. S. L., Montesinos, M. C., Fernandez, P., Desai, A., Delano, D. L., Yee, H., Reiss, A. B., Pillinger, M. H., Chen, J., Schwarzschild, M. A., et al. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706812 · Cited by 229
Cardiovascular adenosine receptors: Expression, actions and interactions
Headrick, J. P., Ashton, K. J., Rose'Meyer, R. B., & Peart, J. N. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.06.002 · Cited by 228
Macle, L., Khairy, P., Weerasooriya, R., Novak, P., Verma, A., Willems, S., Arentz, T., Deisenhofer, I., Veenhuyzen, G., Scavée, C., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60026-5 · Cited by 226
P2X7 receptors mediate ischemic damage to oligodendrocytes
Domercq, M., Perez‐Samartin, A., Aparicio, D., Alberdi, E., Pampliega, O., & Matute, C. (2010) · Glia · doi:10.1002/glia.20958 · Cited by 221
The microglial ATP‐gated ion channel P2X7 as a CNS drug target
Bhattacharya, A., & Biber, K. (2016) · Glia · doi:10.1002/glia.23001 · Cited by 221
P2X ion channel receptors and inflammation
Burnstock, G. (2016) · Purinergic Signalling · doi:10.1007/s11302-015-9493-0 · Cited by 216
Self-citationP2X Receptors in Health and Disease
Burnstock, G., & Kennedy, C. (2011) · Advances in Pharmacology · doi:10.1016/b978-0-12-385526-8.00011-4 · Cited by 213
Self-citationCD73-Deficient Mice Are Resistant to Carcinogenesis
Stagg, J., Beavis, P. A., Divisekera, U., Liu, M. C. P., Möller, A., Darcy, P. K., & Smyth, M. J. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0420 · Cited by 211
Mechanisms of the psychostimulant effects of caffeine: implications for substance use disorders
Ferré, S. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4212-2 · Cited by 208
Extracellular ATP and adenosine: The Yin and Yang in immune responses?
Faas, M. M., Sáez, T., & de Vos, P. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.01.002 · Cited by 208
A Polymorphism in the P2X 7 Gene Increases Susceptibility to Extrapulmonary Tuberculosis
Fernando, S. L., Saunders, B. M., Sluyter, R., Skarratt, K. K., Goldberg, H., Marks, G. B., Wiley, J. S., & Britton, W. J. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200607-970oc · Cited by 203
Adenosine A2B Receptor Blockade Slows Growth of Bladder and Breast Tumors
Cekic, C., Sag, D., Li, Y., Theodorescu, D., Strieter, R. M., & Linden, J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101845 · Cited by 201
Burnstock, G. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.05.031 · Cited by 199
Self-citationAdenosine receptor targets for pain
Sawynok, J. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.10.031 · Cited by 199
Remyelination after spinal cord injury: Is it a target for repair?
Plemel, J. R., Keough, M. B., Duncan, G. J., Sparling, J. S., Yong, V. W., Stys, P. K., & Tetzlaff, W. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.02.006 · Cited by 197
Zhao, J., Wang, H., Dai, C., Wang, H., Zhang, H., Huang, Y., Wang, S., Gaskin, F., Yang, N., & Man Fu, S. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38174 · Cited by 192
Purinergic receptors in the carotid body as a new drug target for controlling hypertension
Pijacka, W., Moraes, D. J. A., Ratcliffe, L. E. K., Nightingale, A. K., Hart, E. C., da Silva, M. P., Machado, B. H., McBryde, F. D., Abdala, A. P., Ford, A. P., et al. (2016) · Nature Medicine · doi:10.1038/nm.4173 · Cited by 192
Purinergic signaling in special senses
Housley, G. D., Bringmann, A., & Reichenbach, A. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.01.001 · Cited by 188
Amoroso, F., Capece, M., Rotondo, A., Cangelosi, D., Ferracin, M., Franceschini, A., Raffaghello, L., Pistoia, V, Varesio, L., & Adinolfi, E. (2015) · Oncogene · doi:10.1038/onc.2014.444 · Cited by 185
P2X RECEPTORS AND THEIR ROLE IN FEMALE IDIOPATHIC DETRUSOR INSTABILITY
O’REILLY, B. A., KOSAKA, A. H., KNIGHT, G. F., CHANG, T. K., FORD, A. P. D. W., RYMER, J. M., POPERT, R., BURNSTOCK, G., & McMAHON, S. B. (2002) · Journal of Urology · doi:10.1016/s0022-5347(05)65403-1 · Cited by 185
Self-citationAdenosine signalling in diabetes mellitus—pathophysiology and therapeutic considerations
Antonioli, L., Blandizzi, C., Csóka, B., Pacher, P., & Haskó, G. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.10 · Cited by 183
Neurovascular contributions to migraine: Moving beyond vasodilation
Jacobs, B., & Dussor, G. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.06.012 · Cited by 183
Nanobodies that block gating of the P2X7 ion channel ameliorate inflammation
Danquah, W., Meyer-Schwesinger, C., Rissiek, B., Pinto, C., Serracant-Prat, A., Amadi, M., Iacenda, D., Knop, J.-H., Hammel, A., Bergmann, P., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf8463 · Cited by 182
Pyrophosphate: a key inhibitor of mineralisation
Orriss, I. R., Arnett, T. R., & Russell, R. G. G. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.03.003 · Cited by 181
Switching P2Y12-receptor inhibitors in patients with coronary artery disease
Rollini, F., Franchi, F., & Angiolillo, D. J. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.113 · Cited by 177
Accelerated Tumor Progression in Mice Lacking the ATP Receptor P2X7
Adinolfi, E., Capece, M., Franceschini, A., Falzoni, S., Giuliani, A. L., Rotondo, A., Sarti, A. C., Bonora, M., Syberg, S., Corigliano, D., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1259 · Cited by 176
ATP is released from guinea pig ureter epithelium on distension
Knight, G. E., Bodin, P., De Groat, W. C., & Burnstock, G. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00293.2000 · Cited by 173
Self-citationTsuda, M., Koga, K., Chen, T., & Zhuo, M. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14001 · Cited by 173
Zhu, J., Zeng, Y., Li, W., Qin, H., Lei, Z., Shen, D., Gu, D., Huang, J.-A., & Liu, Z. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0591-1 · Cited by 172
P2X7 receptor signaling contributes to tissue factor–dependent thrombosis in mice
Furlan-Freguia, C., Marchese, P., Gruber, A., Ruggeri, Z. M., & Ruf, W. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46129 · Cited by 169
Prognostic impact of CD73 and A2A adenosine receptor expression in non-small-cell lung cancer
Inoue, Y., Yoshimura, K., Kurabe, N., Kahyo, T., Kawase, A., Tanahashi, M., Ogawa, H., Inui, N., Funai, K., Shinmura, K., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14434 · Cited by 169
The P2X7 Receptor-Interleukin-1 Liaison
Giuliani, A. L., Sarti, A. C., Falzoni, S., & Di Virgilio, F. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00123 · Cited by 166
Purinergic signalling in the urinary tract in health and disease
Burnstock, G. (2014) · Purinergic Signalling · doi:10.1007/s11302-013-9395-y · Cited by 166
Self-citationPurinergic signalling in brain ischemia
Pedata, F., Dettori, I., Coppi, E., Melani, A., Fusco, I., Corradetti, R., & Pugliese, A. M. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.11.007 · Cited by 165
Feng, Y., Li, X., Wang, L., Zhou, L., & Gorodeski, G. I. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602999200 · Cited by 162
Purinergic Signaling in the Airways
Burnstock, G., Brouns, I., Adriaensen, D., & Timmermans, J. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.005389 · Cited by 160
Self-citationYan, D. L. S., Zhu, Y., Walsh, T., Xie, D., Yuan, H., Sırmacı, A., Fujikawa, T., Wong, A. C. Y., Loh, T. L., Du, L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222285110 · Cited by 158
From Mechanosensitivity to Inflammatory Responses: New Players in the Pathology of Glaucoma
Križaj, D., Ryskamp, D. A., Tian, N., Tezel, G., Mitchell, C. H., Slepak, V. Z., & Shestopalov, V. I. (2014) · Current Eye Research · doi:10.3109/02713683.2013.836541 · Cited by 158
Petrášek, J., Iracheta‐Vellve, A., Saha, B., Satishchandran, A., Kodys, K., Fitzgerald, K. A., Kurt‐Jones, E. A., & Szabó, G. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ab1214-590r · Cited by 158
Borel, F., Han, R., Visser, A., Petry, H., van Deventer, S. J. H., Jansen, P. L. M., & Konstantinova, P. S. (2011) · Hepatology · doi:10.1002/hep.24682 · Cited by 157
Altered purinergic signaling in CD73‐deficient mice inhibits tumor progression
Yegutkin, G. G., Marttila‐Ichihara, F., Karikoski, M., Niemelä, J., Laurila, J. P., Elima, K., Jalkanen, S., & Salmi, M. (2011) · European Journal of Immunology · doi:10.1002/eji.201041292 · Cited by 156
Adenosine and inflammation: what's new on the horizon?
Antonioli, L., Csóka, B., Fornai, M., Colucci, R., Kókai, E., Blandizzi, C., & Haskó, G. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.02.010 · Cited by 154
Matos, M., Shen, H.-Y., Augusto, E., Wang, Y., Wei, C. J., Wang, Y. T., Agostinho, P., Boison, D., Cunha, R. A., & Chen, J.-F. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.02.026 · Cited by 153
Ni, R., Zheng, D., Xiong, S., Hill, D. J., Sun, T., Gardiner, R. B., Fan, G., Lu, Y., Abel, E. D., Greer, P. A., et al. (2015) · Diabetes · doi:10.2337/db15-0963 · Cited by 150
Dendritic cells tolerized with adenosine A2AR agonist attenuate acute kidney injury
Li, L., Huang, L., Ye, H., Song, S., Bajwa, A., Lee, S. J., Moser, E. K., Jaworska, K., Kinsey, G. R., Day, Y., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63170 · Cited by 149
Anthraquinone emodin inhibits human cancer cell invasiveness by antagonizing P2X7 receptors
Jelassi, B., Anchelin, M., Chamouton, J., Cayuela, M. L., Clarysse, L., Li, J., Goré, J., Jiang, L., & Roger, S. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt099 · Cited by 146
Feng, L., Sun, X., Csizmadia, E., Han, L., Shu, B., Murakami, T., Wang, X., Robson, S. C., & Wu, Y. (2011) · Neoplasia · doi:10.1593/neo.101332 · Cited by 145
Csóka, B., Németh, Z. H., Törő, G., Idzko, M., Zech, A., Koscsó, B., Spolarics, Z., Antonioli, L., Cseri, K., Erdélyi, K., et al. (2015) · The FASEB Journal · doi:10.1096/fj.15-272450 · Cited by 143
Smith, C. P., Vemulakonda, V. M., Kiss, S., Boone, T. B., & Somogyi, G. T. (2005) · Neurochemistry International · doi:10.1016/j.neuint.2005.04.021 · Cited by 143
Purinergic Signaling in Healthy and Diseased Skin
Burnstock, G., Knight, G. E., & Greig, A. V. H. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.344 · Cited by 143
Self-citationKimbler, D. E., Shields, J., Yanasak, N. E., Vender, J. R., & Dhandapani, K. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041229 · Cited by 143
Dragicevic, E., Schiemann, J. M., & Liss, B. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.10.037 · Cited by 141
Matsumura, Y., Yamashita, T., Sasaki, A., Nakata, E., Kohno, K., Masuda, T., Tozaki‐Saitoh, H., Imai, T., Kuraishi, Y., Tsuda, M., et al. (2016) · Scientific Reports · doi:10.1038/srep32461 · Cited by 140
Hu, X., Liou, A. K. F., Leak, R. K., Xu, M., An, C., Suenaga, J., Shi, Y., Gao, Y., Zheng, P., & Chen, J. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.06.002 · Cited by 139
Eser, A., Colombel, J., Rutgeerts, P. J., Vermeire, S., Vogelsang, H., Braddock, M., Persson, T., & Reinisch, W. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000514 · Cited by 138
Hoque, R., Sohail, M. A., Salhanick, S. D., Malik, A. F., Ghani, A., Robson, S. C., & Mehal, W. Z. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00352.2011 · Cited by 138
Glomerular expression of the ATP-sensitive P2X7 receptor in diabetic and hypertensive rat models
Vonend, O., Turner, C. M., Chan, C. M., Loesch, A., Dell'Anna, G. C., Srai, S. K., Burnstock, G., & Unwin, R. J. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00717.x · Cited by 135
Self-citationNaviaux, J. C., Schuchbauer, M. A., Li, K., Wang, L., Risbrough, V. B., Powell, S. B., & Naviaux, R. K. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.33 · Cited by 134
Therapeutic potential of adenosine kinase inhibitors
Kowaluk, E. A., & Jarvis, M. F. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.3.551 · Cited by 133
Pharmacologic perspective on the physiology of the lower urinary tract
Andersson, K., & Hedlund, P. (2002) · Urology · doi:10.1016/s0090-4295(02)01786-7 · Cited by 133
Cardiac purinergic signalling in health and disease
Burnstock, G., & Pelleg, A. (2014) · Purinergic Signalling · doi:10.1007/s11302-014-9436-1 · Cited by 132
Self-citationFiebich, B. L., Akter, S., & Akundi, R. S. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00260 · Cited by 132
Fishman, P. (1992) · International Journal of Oncology · doi:10.3892/ijo_00000008 · Cited by 132
Corciulo, C., Lendhey, M., Wilder, T., Schoen, H., Cornelissen, A. S., Chang, G. A., Kennedy, O. D., & Cronstein, B. N. (2017) · Nature Communications · doi:10.1038/ncomms15019 · Cited by 131
Systemic blockade of P2X3 and P2X2/3 receptors attenuates bone cancer pain behaviour in rats
Kaan, T. K. Y., Yip, P. K., Patel, S., Davies, M., Marchand, F., Cockayne, D. A., Nunn, P. A., Dickenson, A. H., Ford, A. P. D. W., Zhong, Y., et al. (2010) · Brain · doi:10.1093/brain/awq194 · Cited by 130
Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics
Ortiz, R., Ulrich, H., Zarate, C. A., & Machado‐Vieira, R. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.10.016 · Cited by 129
Sanderson, J., Dartt, D. A., Trinkaus‐Randall, V., Pintor, J. J., Civan, M. M., Delamere, N. A., Fletcher, E. L., Salt, T. E., Grosche, A., & Mitchell, C. H. (2014) · Experimental Eye Research · doi:10.1016/j.exer.2014.08.009 · Cited by 128
Purinergic Mechanosensory Transduction and Visceral Pain
Burnstock, G. (2009) · Molecular Pain · doi:10.1186/1744-8069-5-69 · Cited by 128
Self-citationP2X7 Deficiency Attenuates Renal Injury in Experimental Glomerulonephritis
Taylor, S. R. J., Turner, C. M., Elliott, J. I., McDaid, J., Hewitt, R., Smith, J., Pickering, M. C., Whitehouse, D. L., Cook, H. T., Burnstock, G., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008060559 · Cited by 127
Self-citationAdenosine and its receptors as therapeutic targets: An overview
Sachdeva, S., & Gupta, M. (2012) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2012.05.011 · Cited by 126
Purinergic signalling and diabetes
Burnstock, G., & Novak, I. (2013) · Purinergic Signalling · doi:10.1007/s11302-013-9359-2 · Cited by 126
Self-citationLiu, S., Zou, L., Xie, J., Xie, W., Wen, S., Xie, Q., Gao, Y., Li, G., Zhang, C., Xu, C., et al. (2016) · Molecular Brain · doi:10.1186/s13041-016-0226-2 · Cited by 126
Genetics of the P2X7 receptor and human disease
Fuller, S. J., Stokes, L., Skarratt, K. K., Gu, B. J., & Wiley, J. S. (2009) · Purinergic Signalling · doi:10.1007/s11302-009-9136-4 · Cited by 125
Tantry, S. J., Markad, S. D., Shinde, V. N., Bhat, J., Balakrishnan, G., Gupta, A. K., Ambady, A., Raichurkar, A. V., Kedari, C. K., Sharma, S., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01358 · Cited by 125
Purinergic signalling in the musculoskeletal system
Burnstock, G., Arnett, T. R., & Orriss, I. R. (2013) · Purinergic Signalling · doi:10.1007/s11302-013-9381-4 · Cited by 124
Self-citationDrug Insight: biological effects of botulinum toxin A in the lower urinary tract
Chancellor, M. B., Fowler, C. J., Apostolidis, A., de Groat, W. C., Smith, C. P., Somogyi, G. T., & Aoki, K. R. (2008) · Nature Clinical Practice Urology · doi:10.1038/ncpuro1124 · Cited by 123
Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation
Ingwersen, J., Wingerath, B., Graf, J., Lepka, K., Hofrichter, M., Schröter, F., Wedekind, F., Bauer, A., Schrader, J., Hartung, H. ‐., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0512-z · Cited by 123
Cameron, K. O., Kung, D. W., Kalgutkar, A. S. S., Kurumbail, R. G., Miller, R., Salatto, C. T., Ward, J., Withka, J. M., Bhattacharya, S. K., Boehm, M., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00866 · Cited by 123
Apolloni, S., Amadio, S., Parisi, C., Matteucci, A., Potenza, R. L., Armida, M., Popoli, P., D’Ambrosi, N., & Volonté, C. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.017038 · Cited by 121
Shibukawa, Y., Sato, M., Kimura, M., et al. (2014) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-014-1551-x · Cited by 121
Hofman, P. M., Cherfils‐Vicini, J., Bazin, M., Ilié, M., Juhel, T., Hébuterne, X., Gilson, É., Schmid‐Alliana, A., Boyer, O., Adriouch, S., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1778 · Cited by 118
P2X7 receptor stimulates breast cancer cell invasion and migration via the AKT pathway
Xia, J., Yu, X., Tang, L. P., LI, G., & He, T. (2015) · Oncology Reports · doi:10.3892/or.2015.3979 · Cited by 116
Early prostate cancer detected using expression of non‐functional cytolytic P2X7 receptors
Slater, M., Danieletto, S., Gidley-Baird, A. A., Teh, L. C., & Barden, J. A. (2004) · Histopathology · doi:10.1111/j.0309-0167.2004.01798.x · Cited by 116
Guixà-González, R., Javanainen, M., Gómez‐Soler, M., Cordobilla, B., Domingo, J. C., Sanz, F., Pastor, M., Ciruela, F., Martinez‐Seara, H., & Selent, J. (2016) · Scientific Reports · doi:10.1038/srep19839 · Cited by 116
ATP-Induced Inflammation Drives Tissue-Resident Th17 Cells in Metabolically Unhealthy Obesity
Pandolfi, J. B., Ferraro, A., Sananez, I., Gancedo, M. C., Baz, P., Billordo, L. A., Fainboim, L., & Arruvito, L. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502506 · Cited by 116
Purinergic mechanisms in neuroinflammation: An update from molecules to behavior
Beamer, E. H., Gölöncsér, F., Horváth, G., Bekő, K., Otrokocsi, L., Koványi, B., & Sperlágh, B. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.09.019 · Cited by 115
P2X and P2Y Receptors—Role in the Pathophysiology of the Nervous System
Puchałowicz, K., Tarnowski, M., Baranowska‐Bosiacka, I., Chlubek, D., & Dziedziejko, V. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151223672 · Cited by 115
Role of Extracellular Adenosine in Acute Lung Injury
Eckle, T. D. L. G., Koeppen, M., & Eltzschig, H. K. (2009) · Physiology · doi:10.1152/physiol.00022.2009 · Cited by 114
Nylander, S., & Schulz, R. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13429 · Cited by 114
Solini, A., Menini, S., Rossi, C., Ricci, P. C., Santini, E., Fantauzzi, C. B., Iacobini, C., & Pugliese, G. (2013) · The Journal of Pathology · doi:10.1002/path.4237 · Cited by 113
Targeting Therapy for Breast Carcinoma by ATP Synthase Inhibitor Aurovertin B
Huang, T., Chang, H., Hsu, C., Kuo, W., Chang, K., & Juan, H. (2008) · Journal of Proteome Research · doi:10.1021/pr700742h · Cited by 111
Killeen, M. E., Ferris, L. K., Kupetsky, E. A., Falo, L. D., & Mathers, A. R. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202045 · Cited by 111
Purinergic receptors as potential therapeutic targets in Alzheimer's disease
Woods, L. T., Ajit, D., Camden, J. M., Erb, L., & Weisman, G. A. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.031 · Cited by 109
The ATP-Gated P2X7 Receptor As a Target for the Treatment of Drug-Resistant Epilepsy
Beamer, E. H., Fischer, W., & Engel, T. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00021 · Cited by 109
White matter injury: Ischemic and nonischemic
Fern, R. F., Matute, C., & Stys, P. K. (2014) · Glia · doi:10.1002/glia.22722 · Cited by 108
Ongaro, A., Varani, K., Masieri, F. F., Pellati, A., Massari, L., Cadossi, R., Vincenzi, F., Borea, P. A., Fini, M., Caruso, A., et al. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22981 · Cited by 108
Neves, A. R., Castelo-Branco, M. T. L., Figliuolo, V. R., Bernardazzi, C., Buongusto, F., Yoshimoto, A., Nanini, H. F., Coutinho, C. M. L. M., Carneiro, A. J. V., Coutinho-Silva, R., et al. (2014) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000441201.10454.06 · Cited by 107
Jiang, S., Zhang, Y., Zheng, J., Li, X., Yao, Y., Wu, Y., Song, S., Sun, P., Nan, J., & Lian, L. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.11.040 · Cited by 107
Ghanem, E. N. B., Clark, S. A., Roggensack, S. E., McIver, S. R., Alcaide, P., Haydon, P. G., & Leong, J. M. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005126 · Cited by 106
Maminishkis, A., Jalickee, S., Blaug, S., Rymer, J., Yerxa, B. R., Peterson, W. M., & Miller, S. S. (2002) · PubMed · Cited by 105
Thevananther, S., Sun, H., Li, D., Arjunan, V., Awad, S. S., Wyllie, S., Zimmerman, T. L., Goss, J. A., & Karpen, S. J. (2004) · Hepatology · doi:10.1002/hep.20075 · Cited by 105
Purinergic Signalling and the Nervous System
Burnstock, G., & Verkhratsky, A. (2012) · Springer eBooks · doi:10.1007/978-3-642-28863-0 · Cited by 105
Self-citationPurinergic signaling in kidney disease
Menzies, R. I., Tam, F. W. K., Unwin, R. J., & Bailey, M. A. (2016) · Kidney International · doi:10.1016/j.kint.2016.08.029 · Cited by 105
γ-Irradiation induces P2X7 receptor-dependent ATP release from B16 melanoma cells
Ohshima, Y., Tsukimoto, M., Takenouchi, T., et al. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.10.008 · Cited by 104
Targeting of the P2X7 receptor in pancreatic cancer and stellate cells
Giannuzzo, A., Saccomano, M., Napp, J., Ellegaard, M., Alves, F., & Novak, I. (2016) · International Journal of Cancer · doi:10.1002/ijc.30380 · Cited by 104
Jimenez-Mateos, E. M., Arribas-Blazquez, M., Sanz-Rodriguez, A., Concannon, C., Olivos-Ore, L. A., Reschke, C. R., Mooney, C. M., Mooney, C., Lugara, E., Morgan, J., et al. (2015) · Scientific Reports · doi:10.1038/srep17486 · Cited by 103
Trophic Activity of Human P2X7 Receptor Isoforms A and B in Osteosarcoma
Giuliani, A. L., Colognesi, D., Ricco, T., Roncato, C., Capece, M., Amoroso, F., Wang, Q., Marchi, E. D., Gartland, A., Virgilio, F. D., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107224 · Cited by 103
A taste for ATP: neurotransmission in taste buds
Kinnamon, S. C., & Finger, T. E. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00264 · Cited by 103
Lee, B. H., Hwang, D. M., Palaniyar, N., Grinstein, S., Philpott, D. J., & Hu, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035812 · Cited by 102
Mediavilla-Varela, M., Luddy, K. A., Noyes, D. R., Khalil, F. K., Neuger, A. M., Soliman, H. H., & Antonia, S. J. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.25643 · Cited by 102
Amaral, E. P., Ribeiro, S. C. M., Lanes, V. R., Almeida, F. M., de Andrade, M. R. M., Bomfim, C. C. B., de Salles, É. M., Bortoluci, K. R., Coutinho‐Silva, R., Hirata, M. H., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004188 · Cited by 102
Role of the ectonucleotidase NTPDase2 in taste bud function
Vandenbeuch, A., Anderson, C. B., Parnes, J. A., Enjyoji, K., Robson, S. C., Finger, T. E., & Kinnamon, S. C. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309468110 · Cited by 101
Polycystins and renovascular mechanosensory transduction
Patel, A. J., & Honoré, É. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.97 · Cited by 101
Regulation of Fear Responses by Striatal and Extrastriatal Adenosine A2A Receptors in Forebrain
Wei, C. J., Augusto, E., Gomes, C. A., Singer, P., Wang, Y., Boison, D., Cunha, R. A., Yee, B. K., & Chen, J. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.05.003 · Cited by 100
Ayata, C. K., Ganal-Vonarburg, S. C., Hockenjos, B., Willim, K., Vieira, R. P., Grimm, M., Robaye, B., Boeynaems, J. M., Virgilio, F. D., Pellegatti, P., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.08.049 · Cited by 100
Purinergic Signalling: Pathophysiology and Therapeutic Potential
Burnstock, G. (2013) · The Keio Journal of Medicine · doi:10.2302/kjm.2013-0003-re · Cited by 100
Self-citationGuzman, S. J., & Gerevich, Z. (2016) · Neural Plasticity · doi:10.1155/2016/1207393 · Cited by 100
Allosteric mechanisms within the adenosine A2A–dopamine D2 receptor heterotetramer
Ferré, S., Bonaventura, J., Tomasi, D. G., Navarro, G., Moreno, E., Cortés, A., Lluı́s, C., Casadó, V., & Volkow, N. D. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.05.028 · Cited by 99
ATP Signaling in Brain: Release, Excitotoxicity and Potential Therapeutic Targets
Cisneros-Mejorado, A., Pérez‐Samartín, A., Gottlieb, M., & Matute, C. (2014) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-014-0092-3 · Cited by 99
Alves, L. A., Soares‐Bezerra, R. J., Faria, R. X., Ferreira, L., & Frutuoso, V. D. S. (2013) · Molecules · doi:10.3390/molecules180910953 · Cited by 99
P2Y 12 Receptor Modulates Sepsis-Induced Inflammation
Liverani, E., Rico, M. C., Tsygankov, A. Y., Kilpatrick, L. E., & Kunapuli, S. P. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307401 · Cited by 99
Critical role of P2X7 receptors in the neuroinflammation and cognitive dysfunction after surgery
Zheng, B., Lai, R., Li, J., & Zuo, Z. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.01.005 · Cited by 99
P2X7 Receptors Regulate NKT Cells in Autoimmune Hepatitis
Kawamura, H., Aswad, F., Minagawa, M., Govindarajan, S., & Dennert, G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2152 · Cited by 98
Evidence for Bladder Urothelial Pathophysiology in Functional Bladder Disorders
KEAY, S. K., Birder, L. A., & Chai, T. C. (2014) · BioMed Research International · doi:10.1155/2014/865463 · Cited by 98
Metzger, M. W., Walser, S. M., Aprile-Garcia, F., Dedic, N., Chen, A., Holsboer, F., ARZT, E. S., Wurst, W., & Deussing, J. M. (2016) · Purinergic Signalling · doi:10.1007/s11302-016-9546-z · Cited by 98
Adenosine A3 Receptor Suppresses Prostate Cancer Metastasis by Inhibiting NADPH Oxidase Activity
Jajoo, S., Mukherjea, D., Watabe, K., & Ramkumar, V. (2009) · Neoplasia · doi:10.1593/neo.09744 · Cited by 97
Purinergic receptors in psychiatric disorders
Krügel, U. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.032 · Cited by 97
Nucleotide Salvage Deficiencies, DNA Damage and Neurodegeneration
Fasullo, M., & Endres, L. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16059431 · Cited by 97
ATPergic signalling during seizures and epilepsy
Engel, T., Alves, M., Sheedy, C., & Henshall, D. C. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.11.001 · Cited by 97
Loss of CD73-mediated actin polymerization promotes endometrial tumor progression
Bowser, J. L., Blackburn, M. R., Shipley, G. L., Molina, J. G., Dunner, K., & Broaddus, R. R. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79380 · Cited by 97
Involvement of Adenosine A2A Receptors in Depression and Anxiety
Yamada, K., Kobayashi, M., & Kanda, T. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801022-8.00015-5 · Cited by 97
Xie, R., Xu, J., Wen, G., Jin, H. D., Liu, X., Yang, Y., Ji, B., Jiang, Y., Song, P., Dong, H. F., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.540047 · Cited by 96
Vandenbeuch, A., Larson, E. D., Anderson, C. B., Smith, S. A., Ford, A. P. D. W., Finger, T. E., & Kinnamon, S. C. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.281014 · Cited by 96
ATP acts as a survival signal and prevents the mineralization of aortic valve
Côté, N., El Husseini, D., Pépin, A., Guauque-Olarte, S., Ducharme, V., Bouchard-Cannon, P., Audet, A., Fournier, D., Gaudreault, N., Derbali, H., et al. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.02.003 · Cited by 95
The therapeutic promise of ATP antagonism at P2X3 receptors in respiratory and urological disorders
Ford, A. P., & Undem, B. J. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00267 · Cited by 95
Hu, S. J., Calippe, B., Lavalette, S., Roubeix, C., Montassar, F., Housset, M., Levy, O., Delarasse, C., Pâques, M., Sahel, J., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.3955-14.2015 · Cited by 95
Therapeutic implications of central and peripheral neurologic mechanisms in migraine
Waeber, C., & Moskowitz, M. A. (2003) · Neurology · doi:10.1212/wnl.61.8_suppl_4.s9 · Cited by 95
Hypoxia-inducible adenosine A2B receptor modulates proliferation of colon carcinoma cells
Ma, D., Kondo, T., Nakazawa, T., Niu, D., Mochizuki, K., Kawasaki, T., Yamane, T., & Katoh, R. (2010) · Human Pathology · doi:10.1016/j.humpath.2010.04.008 · Cited by 95
Extracellular ATP mediates inflammatory responses in colitis via P2 × 7 receptor signaling
Wan, P., Liu, X., Xiong, Y., Ren, Y., Jiang, C., Lü, N., Guo, Y., & Bai, A. (2016) · Scientific Reports · doi:10.1038/srep19108 · Cited by 95
CF102 for the Treatment of Hepatocellular Carcinoma: A Phase I/II, Open-Label, Dose-Escalation Study
Stemmer, S. M., Benjaminov, O., Medalia, G., Ciuraru, N. B., Silverman, M. H., Bar‐Yehuda, S., Fishman, S., Harpaz, Z., Farbstein, M., Cohen, S., et al. (2012) · The Oncologist · doi:10.1634/theoncologist.2012-0211 · Cited by 93
Purinergic signalling in the liver in health and disease
Burnstock, G., Vaughn, B. P., & Robson, S. C. (2013) · Purinergic Signalling · doi:10.1007/s11302-013-9398-8 · Cited by 93
Self-citationPurinergic signalling in the kidney in health and disease
Burnstock, G., Evans, L. C., & Bailey, M. A. (2013) · Purinergic Signalling · doi:10.1007/s11302-013-9400-5 · Cited by 92
Self-citationPurinergic Signaling During Immune Cell Trafficking
Ferrari, D., McNamee, E. N., Idzko, M., Gambari, R., & Eltzschig, H. K. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.04.004 · Cited by 92
Li, W., Silva, H. B. L., Real, J. I., Wang, Y., Rial, D., Li, P., Payen, M.-P., Zhou, Y., Müller, C. E., Tomé, Â. R., et al. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.03.030 · Cited by 91
Ou, Z., Sun, Y., Li, L., You, N., Liu, X., Li, H., Ma, Y., Cao, L., Han, Y., Liu, M., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0898-16.2016 · Cited by 91
Mattei, M. D., Varani, K., Masieri, F. F., Pellati, A., Ongaro, A., Fini, M., Cadossi, R., Vincenzi, F., Borea, P. A., & Caruso, A. (2008) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2008.06.002 · Cited by 90
P2X7 receptor-deficient mice are susceptible to bone cancer pain
Hansen, R. R., Nielsen, C. K., Nasser, A., Thomsen, S. I. M., Eghorn, L. F., Pham, Y., Schulenburg, C., Syberg, S., Ding, M. L., Stojilković, S. S., et al. (2011) · Pain · doi:10.1016/j.pain.2011.03.024 · Cited by 90
P2X7 as a new target for chrysophanol to treat lipopolysaccharide-induced depression in mice
Zhang, K., Liu, J., You, X., Kong, P., Song, Y., Cao, L., Yang, S. T., Wang, W., Fu, Q., & Ma, Z. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.12.043 · Cited by 90
The P2X7receptor as a therapeutic target
Romagnoli, R., Baraldi, P. G., Cruz‐López, O., Lopez-Cara, L. C., Preti, D., Borea, P. A., & Gessi, S. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.5.647 · Cited by 89
Cited by
The P2X7 Receptor in Inflammatory Diseases: Angel or Demon?
Savio, L. E. B., de Andrade Mello, P., da Silva, C. G., & Coutinho-Silva, R. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00052 · Cited by 437
Danger signals in stroke and their role on microglia activation after ischemia
Gülke, E., Gelderblom, M., & Magnus, T. (2018) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286418774254 · Cited by 321
Mechanisms of ATP Release by Inflammatory Cells
Dosch, M., Gerber, J., Jebbawi, F., & Beldi, G. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041222 · Cited by 283
Metadata
- Authors
- Burnstock, G.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2017-09-25
- Volume
- 8
- Pages
- 661-661
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2759752974
- Cited by
- 398
- References
- 724
- FWCI
- 28.49
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.